Nuwellis, Inc. (NUWE)
NUWE Stock Price Chart
Explore Nuwellis, Inc. interactive price chart. Choose custom timeframes to analyze NUWE price movements and trends.
NUWE Company Profile
Discover essential business fundamentals and corporate details for Nuwellis, Inc. (NUWE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Feb 2012
Employees
38.00
Website
https://www.nuwellis.comCEO
John L. Erb
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
NUWE Financial Timeline
Browse a chronological timeline of Nuwellis, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$60.99 falling short of the estimated -$18.90 by -222.70%, while revenue for the quarter reached $1.73M , missing expectations by -21.59%.
Stock split effective on 7 Jul 2025
Shares were split 1 : 42 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2025
EPS came in at -$28.99 falling short of the estimated -$18.91 by -53.31%, while revenue for the quarter reached $1.90M , missing expectations by -13.45%.
Earnings released on 11 Mar 2025
EPS came in at -$0.65 falling short of the estimated -$0.43 by -51.16%, while revenue for the quarter reached $2.32M , missing expectations by -7.12%.
Earnings released on 11 Nov 2024
EPS came in at $1.74 surpassing the estimated -$1.28 by +235.94%, while revenue for the quarter reached $2.37M , missing expectations by -3.84%.
Earnings released on 13 Aug 2024
EPS came in at -$18.85 falling short of the estimated -$9.49 by -98.63%, while revenue for the quarter reached $2.19M , beating expectations by +9.70%.
Stock split effective on 28 Jun 2024
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 May 2024
EPS came in at -$20.98 falling short of the estimated -$1.06 by -1.88K%, while revenue for the quarter reached $1.86M , missing expectations by -7.15%.
Earnings released on 5 Mar 2024
EPS came in at -$78.32 falling short of the estimated -$1.39 by -5.53K%, while revenue for the quarter reached $2.55M , beating expectations by +0.04%.
Earnings released on 7 Nov 2023
EPS came in at -$63.29 falling short of the estimated -$3.11 by -1.94K%, while revenue for the quarter reached $2.41M , missing expectations by -5.41%.
Earnings released on 8 Aug 2023
EPS came in at -$127.62 falling short of the estimated -$4.02 by -3.07K%, while revenue for the quarter reached $2.08M , missing expectations by -5.25%.
Earnings released on 9 May 2023
EPS came in at -$177.97 falling short of the estimated -$3.79 by -4.60K%, while revenue for the quarter reached $1.83M , missing expectations by -21.97%.
Earnings released on 28 Feb 2023
EPS came in at -$174.83 falling short of the estimated $17.09 by -1.12K%, while revenue for the quarter reached $2.34M , beating expectations by +6.08%.
Stock split effective on 12 Dec 2022
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2022
EPS came in at -$1.29K falling short of the estimated -$32.00 by -3.94K%, while revenue for the quarter reached $2.07M , missing expectations by -9.88%.
Earnings released on 9 Aug 2022
EPS came in at -$1.43K falling short of the estimated -$43.00 by -3.23K%, while revenue for the quarter reached $2.21M , beating expectations by +5.28%.
Earnings released on 10 May 2022
EPS came in at -$1.47K falling short of the estimated -$42.00 by -3.40K%, while revenue for the quarter reached $1.93M , beating expectations by +8.49%.
Earnings released on 1 Mar 2022
EPS came in at -$1.43K falling short of the estimated -$48.00 by -2.89K%, while revenue for the quarter reached $1.64M , missing expectations by -22.24%.
Earnings released on 9 Nov 2021
EPS came in at -$2.62K falling short of the estimated -$73.00 by -3.49K%, while revenue for the quarter reached $1.85M .
Earnings released on 10 Aug 2021
EPS came in at -$2.52K falling short of the estimated -$89.00 by -2.73K%, while revenue for the quarter reached $2.51M .
Earnings released on 11 May 2021
EPS came in at -$4.37K falling short of the estimated -$116.00 by -3.67K%, while revenue for the quarter reached $1.92M , beating expectations by +8.41%.
Earnings released on 2 Mar 2021
EPS came in at -$157.00 surpassing the estimated -$191.00 by +17.80%, while revenue for the quarter reached $2.04M .
Earnings released on 10 Nov 2020
EPS came in at -$208.00 falling short of the estimated -$183.00 by -13.66%, while revenue for the quarter reached $1.90M , beating expectations by +15.82%.
Stock split effective on 19 Oct 2020
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
NUWE Stock Performance
Access detailed NUWE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.